Moderna initiated with a Hold at Berenberg
Berenberg analyst Harry Gillis initiated coverage of Moderna (MRNA) with a Hold rating and $42 price target. The firm says mRNA will ...
HSBC upgrades Moderna to Buy on pipeline potential
HSBC analyst Yifeng Liu upgraded Moderna (MRNA) to Buy from Hold with a price target of $58, down from $82. The recent share ...
Nasdaq 100 Halts Five-Day Slide as Treasuries Gain: Markets Wrap
Stocks climbed as Treasuries halted a selloff that drove 10-year yields near 4.5%, with traders keeping a close eye on news ...
Business Insider23h
Berenberg Bank Sticks to Its Hold Rating for Moderna (MRNA)
In addition to Berenberg Bank, Moderna also received a Hold from HSBC’s Yifeng Liu in a report issued yesterday. However, on the same day, Piper Sandler maintained a Buy rating on Moderna (NASDAQ: ...
Fintel on MSN23h
HSBC Upgrades Moderna (MRNA)
Fintel reports that on November 18, 2024, HSBC upgraded their outlook for Moderna (NasdaqGS:MRNA) from Hold to Buy. Analyst ...